Stroke prevention device misses key goal in study

by Marilynn Marchione

The future is unclear for a promising heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat.

Early results from a key study of Boston Scientific Corp.'s Watchman device suggest it is safer than previous testing suggested, but may not be as good as a drug that is used now for preventing strokes, heart-related deaths and in people with atrial . That condition causes the heart to flutter rather than beat as it should, which can lead to clots that cause strokes.

The results were to have been the top study at an American College of Cardiology conference in San Francisco on Saturday but the presentation was pulled because the company released results early.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Stroke-preventing technology demonstrated in JoVE

Feb 28, 2012

In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million ...

FDA clears anticlotting drug Eliquis

Dec 28, 2012

The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...

Recommended for you

Location of body fat can increase hypertension risk

7 hours ago

People with fat around their abdominal area are at greater risk of developing hypertension when compared to those with similar body mass index but fat concentrations elsewhere on the body, according to a ...

Fruit consumption cuts CVD risk by up to 40 percent

11 hours ago

Daily fruit consumption cuts the risk of cardiovascular disease (CVD) by up to 40%, according to research presented at ESC Congress today by Dr Huaidong Du from Oxford, UK. The findings from the seven year ...

User comments